Complex I assembly function and fatty acid oxidation enzyme activity of ACAD9 both contribute to disease severity in ACAD9 deficiency
Open Access
- 26 February 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 24 (11) , 3238-3247
Abstract
Acyl-CoA dehydrogenase 9 (ACAD9) is an assembly factor for mitochondrial respiratory chain Complex I (CI), and ACAD9 mutations are recognized as a frequent cause of CI deficiency. ACAD9 also retains enzyme ACAD activity for long-chain fatty acids in vitro, but the biological relevance of this function remains controversial partly because of the tissue specificity of ACAD9 expression: high in liver and neurons and minimal in skin fibroblasts. In this study, we hypothesized that this enzymatic ACAD activity is required for full fatty acid oxidation capacity in cells expressing high levels of ACAD9 and that loss of this function is important in determining phenotype in ACAD9-deficient patients. First, we confirmed that HEK293 cells express ACAD9 abundantly. Then, we showed that ACAD9 knockout in HEK293 cells affected long-chain fatty acid oxidation along with Cl, both of which were rescued by wild type ACAD9. Further, we evaluated whether the loss of ACAD9 enzymatic fatty acid oxidation affects clinical severity in patients with ACAD9 mutations. The effects on ACAD activity of 16 ACAD9 mutations identified in 24 patients were evaluated using a prokaryotic expression system. We showed that there was a significant inverse correlation between residual enzyme ACAD activity and phenotypic severity of ACAD9-deficient patients. These results provide evidence that in cells where it is strongly expressed, ACAD9 plays a physiological role in fatty acid oxidation, which contributes to the severity of the phenotype in ACAD9-deficient patients. Accordingly, treatment of ACAD9 patients should aim at counteracting both CI and fatty acid oxidation dysfunctions.Keywords
This publication has 55 references indexed in Scilit:
- Natural disease course and genotype‐phenotype correlations in Complex I deficiency caused by nuclear gene defects: what we learned from 130 casesJournal of Inherited Metabolic Disease, 2012
- Molecular Diagnosis of Infantile Mitochondrial Disease with Targeted Next-Generation SequencingScience Translational Medicine, 2012
- HSD10 disease: clinical consequences of mutations in the HSD17B10 geneJournal of Inherited Metabolic Disease, 2011
- Mechanism of Hyperinsulinism in Short-chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency Involves Activation of Glutamate DehydrogenaseJournal of Biological Chemistry, 2010
- Evidence for Physical Association of Mitochondrial Fatty Acid Oxidation and Oxidative Phosphorylation ComplexesJournal of Biological Chemistry, 2010
- A non‐enzymatic function of 17β‐hydroxysteroid dehydrogenase type 10 is required for mitochondrial integrity and cell survivalEMBO Molecular Medicine, 2010
- Structural Basis for Substrate Fatty Acyl Chain SpecificityJournal of Biological Chemistry, 2008
- A New Genetic Disorder in Mitochondrial Fatty Acid β-Oxidation: ACAD9 DeficiencyThe American Journal of Human Genetics, 2007
- Expression and characterization of mutations in human very long-chain acyl-CoA dehydrogenase using a prokaryotic systemMolecular Genetics and Metabolism, 2007
- Isovaleric acidemia: New aspects of genetic and phenotypic heterogeneityAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2006